Journal Information
Original articles
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
Agustín Blanco Echevarría, Juan De Dios García Díaz, Assumpta Caixas, Núria Plana Gil, Miguel Ángel Rico Corral, Ian Bridges, Nafeesa Dhalwani, Sònia Gatell Menchen, Kausik K. Ray
Clin Investig Arterioscler. 2023;35:263-71
Full text access
Open Article
Observational study of patients from a Lipid Unit on lipid-modifying therapy for primary and secondary prevention: ULFI Study
Àlex Vila, Estel Pons, Patricia Trinidad García, Daniel Vidal, Sara López, Armand Grau
Clin Investig Arterioscler. 2023;35:272-9
Full text access
Open Article
Original iberoamerican
Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia
Ángel Alberto García-Peña, Mariana Pineda-Posada, Carol Páez-Canro, César Cruz, Daniel Samacá-Samacá
Clin Investig Arterioscler. 2023;35:280-9
Full text access
Open Article
Brief original
Doctors’ perception of red wine consumption and cardiovascular health
Javier Espíldora-Hernández, Salvador Martín-Cortés, María José Benítez-Toledo, Inmaculada Coca-Prieto, Miguel Ángel Sánchez-Chaparro, Pedro Valdivielso
Clin Investig Arterioscler. 2023;35:290-3
Full text access
Open Article
Editorial
Wine: is it really healthy?
Ramón Estruch
Clin Investig Arterioscler. 2023;35:294-6
Full text access
Open Article
Review article
Update of HDL in atherosclerotic cardiovascular disease
Leonie Schoch, Sebastián Alcover, Teresa Padró, Soumaya Ben-Aicha, Guiomar Mendieta, Lina Badimon, Gemma Vilahur
Clin Investig Arterioscler. 2023;35:297-314
Full text access
Open Article